Additionally, the administration of the small molecule, INCB024360, blocking IDO enzymatic activity in murine pancreatic ductal adenocarcinoma significantly inhibits tumor growth in a lymphocyte-dependent manner (78). Here, IDO1 is linked to neoplasm.